Clinical Trial Update: Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet

View source ↗

Summary

A completed postmarketing surveillance study evaluating the safety and efficacy information of Alesion® Tablet in perennial allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• Alesion

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Rhinitis, Allergic, Perennial | Status: COMPLETED